Shandong Sinobioway Biomedicine Co., Ltd. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was CNY 610.638 million compared to CNY 673.760 million a year ago. Operating income was CNY 53.709 million compared to operating loss of CNY 89.702 million a year ago. Net income was CNY 43.778 million compared to net loss of CNY 102.895 million a year ago. Basic earnings per share from continuing operations was CNY 0.0664 compared to basic loss per share from continuing operations of CNY 0.156 a year ago.